Literature DB >> 1678343

Efficacy and outcome of an open access endoscopy service.

J M Hansen1, P Bytzer, S Bondesen, O B Schaffalitzky de Muckadell.   

Abstract

In a retrospective questionnaire-study, we have attempted to elucidate how open access endoscopy influences management of dyspeptic patients, with special focus on young patients (less than 40 year), since the proportion of examinations with findings not requiring medical treatment are consistently reported higher in this age group. During a one-year period, 436 patients referred for open access endoscopy and their general practitioners completed questionnaires giving details of medical treatment, consultation rate for dyspepsia and global assessment before and 6-18 months after the endoscopy. Relevant changes in medical treatment (stopped in patients with no or minor abnormalities or started in patients with major abnormalities) was found for 27% of the patients, irrespective of age group. The result of the endoscopy provided reassurance for 70% of the patients with no or minor abnormalities. Reassurance was coupled with a lower consultation rate and with fewer symptoms. Altogether, 83% of the young patients with no or minor abnormalities had a positive outcome of the endoscopy. As the endoscopy service introduced relevant and lasting prescription habits and reduced consultation rates at general practitioners, also for younger dyspeptic patients with no or minor abnormalities, the strategy generally proposed of a trial with H2-receptor antagonists before considering referral for endoscopy should be subjected to formal clinical trial evaluating all relevant levels of efficacy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678343

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


  8 in total

Review 1.  Unsedated transnasal endoscopy: a safe and less costly alternative.

Authors:  Kia Saeian
Journal:  Curr Gastroenterol Rep       Date:  2002-06

2.  A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.

Authors:  Johanna I Westbrook; Anne E Duggan; John M Duggan; Mary T Westbrook
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Economic costs of functional dyspepsia.

Authors:  O Nyrén; G Lindberg; E Lindström; R Seensalu
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

5.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

6.  Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache.

Authors:  L Howard; S Wessely; M Leese; L Page; P McCrone; K Husain; J Tong; A Dowson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

Review 7.  Testing for Helicobacter pylori in primary care: trouble in store?

Authors:  R Foy; J M Parry; L Murray; C B Woodman
Journal:  J Epidemiol Community Health       Date:  1998-05       Impact factor: 3.710

8.  What happens to patients following open access gastroscopy? An outcome study from general practice.

Authors:  A P Hungin; P R Thomas; M G Bramble; W A Corbett; N Idle; B R Contractor; D C Berridge; G Cann
Journal:  Br J Gen Pract       Date:  1994-11       Impact factor: 5.386

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.